Clinical trial · Observational
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer
NCT00880711CI-TRIAL-00005845FIONAcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose is to collect real life data on the use of fulvestrant in normal clinical practice in Austria and document the clinical benefit of fulvestrant treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Patient with advanced BC, already receiving Faslodex therapy
Primary outcomes (1)
- measure
- Clinical Benefit, defined as the development of at least one of the following stages and holding on for at least 6 month: Complete response, partial response or stable disease
- timeFrame
- Baseline, after 3, 6, 9 month
Secondary outcomes (3)
- measure
- Tolerability
- timeFrame
- After 3, 6, 9 month (as per usual clinical practice)
- measure
- Quality of Life
- timeFrame
- Baseline, after 3, 6, 9 month (as per usual clinical practice)
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Postmenopausal women with hormone receptor-positive locally advanced or metastatic breast cancer * Ability to read and write and complete questionnaires * Provision of written informed consent * Patients who already received a prescription for fulvestrant Exclusion Criteria: * A subject who does not fulfil all the above mentioned inclusion criteria is not allowed to participate in this NIS
References
Publications (0)
Data not yet available
No reference posted for this study.